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A B S T R A C T
Objectives: Within health economic studies, it is often necessary to adjust costs obtained from different time periods for
inﬂation. Nevertheless, many studies do not report the methods used for this in sufﬁcient detail. In this article, we outline the
principal methods used to adjust for inﬂation, with a focus on studies relating to healthcare interventions in low- and
middle-income countries. We also discuss issues relating to converting local currencies to international dollars and US$ and
adjusting cost data collected from other countries or previous studies.
Methods: We outlined the 3 main methods used to adjust for inﬂation for studies in these settings: exchanging the local
currency to US$ or international dollars and then inﬂating using US inﬂation rates (method 1); inﬂating the local currency
using local inﬂation rates and then exchanging to US$ or international dollars (method 2); splitting the costs into tradable
and nontradable resources and using method 1 on the tradable resources and method 2 on the nontradable resources
(method 3).
Results: In a hypothetical example of adjusting a cost of US$100 incurred in Vietnam from 2006 to 2016 prices, the adjusted
cost from the 3 methods were US$116.84, US$172.09, and US$161.04, respectively.
Conclusions: The different methods for adjusting for inﬂation can yield substantially different results. We make
recommendations regarding the most appropriate method for various scenarios. Moving forward, it is vital that studies report
the methodology they use to adjust for inﬂation more transparently.
Keywords: currency changes, global health, health economics, inﬂation, international dollars.
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Introduction
For economic evaluations in healthcare, it is often necessary to
use cost data that have been collected at different time points.
However, because of inﬂation, the purchasing power of a currency
can change (usually decreasing) over time; therefore it can cost
progressively more to provide the same quantity of goods and
services. Within this article, we focus on “inﬂation,” deﬁned as
when the same nominal quantity of currency buys less in terms of
a ﬁxed basket of goods and services (Box 1). We do not describe
the causes of inﬂation or discuss in detail its measurement,1-5 but
focus rather on the approaches to adjust for it within health
economic evaluations and their implications.
As costs measured (or estimated) in different years are not
directly comparable, within health economic studies it is often
necessary to adjust costs obtained from different time periods to
express them in a single base or reference year (Box 1). Without
making such an adjustment, it can be difﬁcult to tell whether a
change in the cost of an intervention over time is due to a change
in the real value of the resources being used or to a change in the
value of the currency used to purchase them.6 Adjusting for
inﬂation captures changes in the value of the currency. This can be
particularly important for the following:
1. Using cost data relating to an intervention that is incurred over
multiple years.6
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2. Comparing costs and cost-effectiveness data from different
analyses that are performed in different years.6 This is needed
when:
 performing systematic literature reviews, parameterizing
cost assumptions within economic evaluations, or making
cost databases;
 comparing economic evaluations conducted in different
countries; and
 comparing incremental cost-effectiveness ratios of studies
conducted in the past to a new cost-effectiveness threshold
that relates to a different year.
Costs that have been adjusted for inﬂation are typically
referred to as constant or real costs, whereas costs that are
unadjusted are referred to as nominal or current costs.6 It is
important to clarify that although discounting (Box 1) and
adjusting for inﬂation are mathematically similar (and sometimes
confused), in economic terms they are different. Adjusting for
inﬂation accounts for how the purchasing power of a ﬁxed
nominal quantity of currency has changed over time, whereas
discounting future costs accounts mainly for the opportunity cost
of spending the money now rather than in the future (Box 1).
Unfortunately, many studies have not reported in sufﬁcient
detail the methods used to adjust for inﬂation. Nevertheless, it is
important to know these methods because different approaches
can have a signiﬁcant impact on the adjusted costs. Inconsistency
in methods of adjustment and a lack of transparency concerning
them can lead to unexplained variation in cost estimates. The
choice of method used to adjust for inﬂation is critical for all
economic evaluations, but becomes even more relevant for
comparing cost estimates from studies in low- and middle-income
countries because of the absence of local costing data, high rates of
inﬂation and ﬂuctuating market exchange rates. It is also typical to
report the adjusted costs in US$ or international dollars in these
settings (Box 1), causing further challenges and methodological
variation regarding currency conversion. None of the currently
available guidelines issued by low- and middle-income countries
for conducting health economic evaluations provide detailed
methodological guidance on how to adjust for inﬂation when
using information from different healthcare settings.7
BOX 1. Key health economic terms.
Base or reference year: The year in which a ﬁxed quantity of currency can buy a ﬁxed basket of goods and services. In practice, the
most recent year for which reliable price data for the basket are available is used as the base year.6
Basket of goods and services: A list of goods and services matched with the proportions in which the individual items enter into
the reference set.
A ﬁxed basket of goods and services: A basket of goods and services in which not only the items on the list and their proportions
have been determined but also their quantities.
Discounting: Healthcare interventions typically incur costs and generate health outcomes and other beneﬁts over a period of time.
Nevertheless, when the economy is growing, there is an opportunity cost to spending money now (ie, “consuming”) when instead it
could be invested (ie, “saving”) so as to generate a return in the future. We do not discuss discounting in detail, but in passing note
that the discount rate is generally held by economists to be composed of 4 distinct terms.19-22 There are 3 (usually nonnegative)
terms that enter positively in the expression for the discount rate: one accounting for impatience (the desire to consume sooner
rather than later), one reﬂecting expected growth (the opportunity cost of consuming now rather than in the future when resources
are usually cheaper because of long-term growth in incomes), and one expressing the relative risk of the investment (which, if riskier
than average, might well lower future consumption and favors consuming now); ﬁnally, there is one that enters negatively,
expressing the aggregate risk of all investments (which favors setting aside precautionary saving, the more, the riskier the overall
environment). To account for these factors, economic evaluations need to weigh costs and beneﬁts occurring in the future
differently to those occurring in the current period. Discounting is the process used to convert costs or beneﬁts occurring in the
future into a “present value,” that is, into the equivalent (consumption) value those costs or beneﬁts would have now.23-25
Discounting (for positive discount rates) makes costs and beneﬁts accruing in the future worth less than those in the present period.
Similarly to adjusting for inﬂation, although taking into account different factors, discounting allows for the comparison of costs and
beneﬁts accruing at different time periods on a like-to-like basis.
Real interest rates: The rate of return of an investment after adjusting for inﬂation. Real interest rates are often used as estimates
of the discount rate.
Tradable versus nontradable resources: Tradable resources are those that can be sold in a different country from that in which
they were produced; that is, they can be exported or imported. Tradable resources typically include items such as laboratory
equipment and drugs. Nontradable resources are those that cannot be exported or imported. Nontradable resources include many
types of services, which typically must be consumed locally (eg, labor inputs). In economic terms, tradable resources have a uniform
cost worldwide, whereas the cost of nontradable resources generally differs by country because of differences in local prices.
Market exchange rate: A market exchange rate determines a currency’s value in relation to other currencies.
Purchasing power parity (PPP) exchange rate: See International dollars (I$).
International dollars (I$): The international dollar is a hypothetical currency unit that is designed to capture differences in relative
prices across different settings. As with discounting and inﬂation, differences in relative prices also differentially affect the
purchasing power of a currency unit, but international dollars are used to adjust for variations in location rather than in time.8,10,15
That is, what US$1 can buy in the United States is not generally the same as what it buys (converted at exchange rates) in, say,
Ghana. Nevertheless, the international dollar is deﬁned such that it would buy in the country of interest a comparable amount of
goods and services as that which US$1 can buy in the reference country, that is, in the United States. As with discounting and
inﬂation adjustment, international dollars are used as a means of comparing the cost of goods and services in different countries
(locations) on a like-to-like basis.10 To convert a currency unit to international dollars, a purchasing power parity (PPP) exchange rate
is used. The PPP exchange rate represents the number of units of a country’s currency required to buy the equivalent quantity of
goods and services as that which US$1 can buy in the United States.10,15 PPP exchange rates are available from the International
Monetary Fund: World Economic Outlook12 and the World Bank.26
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Ultimately, the most appropriate methodology will depend
on the context and aim of the study.6,8 Moving forward, it is
important that studies more clearly describe and justify their
approach while considering its advantages and limitations for the
given context. The aim of this article is to describe various
methods for adjusting for inﬂation for studies relating to
healthcare interventions in low- and middle-income countries,
providing numerical examples and assessing the implications and
potential biases of each method. We make recommendations
regarding the most appropriate method for various scenarios.
Adjusting for Inﬂation
There are different methods that can be used to adjust for
inﬂation and convert costs to a single baseyear.6,9 In studies relating
to healthcare interventions where most of the resources have
relatively stable local prices and have been purchased using the
local currency, it is typical to use the local inﬂation rates and report
the adjusted costs in the local currency (as outlined in Box 2). This is
most likely to occur for studies based in high-income or
upper-middle–income countries. In contrast, in studies relating to
healthcare interventions where most of the resources have
ﬂuctuating local prices or are imported and purchased in foreign
currencies, a variety of methods have been used to adjust
for inﬂation. This ismost likely tooccur for studies based in low-and
somemiddle-income countries. In these cases, it is typical to report
the adjusted costs in US$ or international dollars (Box 1).
In studies relating to healthcare interventions in low- and
middle-income countries, the main factors to consider when
adjusting for inﬂation are the measure of inﬂation, the output
currency, and the adjustment method.
Choice of the Measure of Inﬂation
There are several different measures of inﬂation.10 The 2 main
ones used within health economic studies are the following:
1. The Gross Domestic Product (GDP) implicit price deﬂator: This
reﬂects the price changes of all goods that contribute to a
country’s gross domestic product (GDP), that is, all locally
produced goods.11,12 It is the most general measure of the
overall price level, and the GDP deﬂator for a given period
reﬂects the average annual rate of inﬂation in the economy as a
whole during that period.6,10 An outline of how to use GDP
implicit price deﬂators is provided in Box 2. GDP implicit price
deﬂators are available from the International Monetary Fund:
World Economic Outlook12 and the World Bank.11
2. The consumer price index (CPI): This reﬂects changes in the cost of
a ﬁxed basket of goods and services that households typically
consume.11,12 CPI should be interpretedwith a degree of caution as
BOX 2. Using the GDP implicit price deﬂators or the CPI.
To adjust for inﬂation using GDP implicit price deﬂators or CPI, you multiply the cost by the ratio of the relevant metric from the year
you want to adjust the costs to and the year they are currently in. In the examples below the costs are being adjusted from 2009 to
2016 prices:
Adjusted cost ð2016 pricesÞ¼Cost ð2009 pricesÞ 3 GDP deflator or CPI for 2016
GDP deflator or CPI for 2009
GDP implicit price deﬂator
Country 2008 2009 2010 2011 2012 2013 2014 2015 2016
Ghana 142 164 191 218 251 290 338 393 464
USA 99 100 101 103 105 107 109 110 111
Vietnam 84 89 100 121 135 141 146 146 147
CPI
Country 2008 2009 2010 2011 2012 2013 2014 2015 2016
Ghana 76 90 100 109 116 130 150 176 207
USA 99 98 100 103 105 107 109 109 110
Vietnam 86 92 100 119 129 138 145 146 151
Examples:
GDP implicit price deﬂator:
Ghana: GHS100 (2009 prices) 3 (464/164) = GHS283 (2016 prices)
USA: US$100 (2009 prices) 3 (111/100) = US$111 (2016 prices)
Vietnam: VND100 (2009 prices) 3 (147/89) = VND176 (2016 prices)
CPI:
Ghana: GHS100 (2009 prices) 3 (207/90) = GHS229 (2016 prices)
USA: US$100 (2009 prices) 3 (110/98) = US$112 (2016 prices)
Vietnam: VND100 (2009 prices) 3 (151/92) = VND164 (2016 prices)
The values used within the examples are highlighted in bold italics.
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the sample of the surveyand the deﬁnedﬁxed basket of goods and
services it referencescanvarywidelyacrossdifferent countries,12,13
resulting in inappropriate comparisons. It is questionablewhether
the CPI is reﬂective of the changes in the cost of healthcare
resources across settings because the prices of the goods and
services in the ﬁxed basket are not necessarily related to
healthcare.6,10 CPIs are available from the International Monetary
Fund: World Economic Outlook12 and the World Bank.13 Some
countries alsomonitor and report their ownCPIs. The source of the
CPIs used should be clearly referenced.
These are not the only measures of inﬂation, and some
countries have an index of inﬂation speciﬁcally for goods
produced and consumed in the healthcare sector.14 Nevertheless,
in practice, this measure cannot be used broadly because it is not
widely available across different countries.6,10 In some cases, the
speciﬁc rate of inﬂation for wages is available, although this
measure is typically too narrow to be used as the index of inﬂation
for healthcare interventions as a whole.10
The most appropriate measure of inﬂation to use for adjusting
costs is the one that most closely reﬂects the general price level of
the resources used by the healthcare intervention.6 The dissimilarity
between the different measures of inﬂation will depend on the local
setting and time period. In 2003, the WHO-CHOICE guide to
cost-effectiveness analysis recommended using GDP implicit price
deﬂators (with the CPI measure being the next best alternative).10
Choice of the Output Currency: US$ Versus
International Dollars
Adjusted costs are typically reported in US$ or international
dollars. The international dollar is a hypothetical currency unit
that is designed to capture the differences in relative prices across
different settings8,10,15 (Box 1). For example, I$1 would buy, in the
country of interest, a comparable amount of goods and services as
US$1 in the United States.
An important advantage of international dollars (over US$) is
that they provide a better comparison of the relative cost of
resources across different countries8 (Table 1). Therefore, they
are very useful when reporting costs from different countries. In
addition, the PPP exchange rates (which are used to convert a
currency to international dollars) are typically relatively stable
over time8 (Box 1). In contrast, a disadvantage of using US$ is
that many market exchange rates can vary signiﬁcantly, even
over short periods of time. This can be very extreme when a
currency is ﬂoated (Table 1). For example, in 2011 the market
exchange rate for Myanmar was US$1 to MMK5.44, whereas in
2012 it changed to US$1 to MMK640.65.16 In these situations,
currencies may be converted using black market exchange rates,
making the choice of the appropriate US$ exchange rate
increasingly difﬁcult.
Nevertheless, an important disadvantage is that many
individuals, including policy makers and clinicians, are less
familiar with international dollars compared with US$8 (Table 1).
In addition, PPP exchange rates are harder to measure and
estimate than market-based exchange rates.8 They are estimated
by the International Comparisons Program using surveys
conducted at infrequent intervals, and in between surveys, rates
have to be projected.8,15,17
The choice of whether to present costs in US$ or international
dollars will depend on the aim of the study and its setting(s)
(Table 1). These options are not mutually exclusive, and both can
be reported within the same study. It can be useful to report the
costs in the local currency as well. Within a cost-effectiveness
analysis, the choice will likely be inﬂuenced by the currency
that the decision maker’s budget or process is denominated in.
Table 1. Advantages and disadvantages of the different output currencies and adjustment methods.
Advantages Disadvantages
Output currency
US$ Widely understood.
The medium of exchange for many
international transactions.
Can poorly reﬂect the relative cost of
resources across different countries.
Market-based US$ exchange rates can vary
signiﬁcantly, even over short periods of
time.
I$ Allows a better comparison of the relative
cost of resources across different
countries.
PPP exchange rates are relatively stable
over time.
Many are less familiar with international
dollars.
PPP exchange rates are harder to measure
and estimate than market-based US$
exchange rates.
Adjustment method
Method 1: Exchanging the local currency
to US$ or international dollars and then
inﬂating using US inﬂation rates
US inﬂation rates more accurately reﬂect
the price changes of tradable resources
(which are often globally purchased and
priced) compared with local inﬂation
rates.
US inﬂation rates may not be reﬂective of
the price changes for local nontradable
resources. As US inﬂation rates are
typically lower than local inﬂation rates,
this method can underestimate the
adjusted costs related to the nontradable
resources.
Method 2: Inﬂating the local currency
using local inﬂation rates and then
exchanging to US$ or international
dollars
Local inﬂation rates more accurately reﬂect
the price changes for local nontradable
resources compared with US inﬂation
rates.
Local inﬂation rates may not be reﬂective of
the price changes for tradable resources.
As local inﬂation rates are typically higher
than US inﬂation rates, this method can
overestimate the adjusted cost related to
the tradable resources.
Method 3: A mixed approach Can be more accurate than other methods. Can be difﬁcult to stratify resources into
tradable and nontradable.
Can be difﬁcult to implement on previously
published data.
4 VALUE IN HEALTH - 2019
Choice of the Adjustment Method
The following are the 3 main inﬂation adjustment methods
used in studies relating to studies in low- and middle-income
countries (Figs. 1 and 2).
Adjustment Method 1: Exchanging the Local Currency to
US$ or International Dollars and Then Inﬂating Using US
Inﬂation Rates
Within this method, the costs are ﬁrst converted from the
local currency to US$ or international dollars, using the
exchange rate relating to the time period during which the
cost data were collected. The values are then inﬂated using US
inﬂation rates to the base year of the analysis (Fig. 1A). The
World Bank can be a useful source of exchange rates.16
A limitation of this approach is that the US inﬂation
rates may not be reﬂective of the price changes that have
occurred within many low- and middle-income countries,
particularly for local nontradable resources, such as
personnel (Box 1). When the inﬂation rate for the local
currency is higher than the US inﬂation rate, this method
can underestimate the adjusted cost related to these
nontradable resources.
Figure 1. Overview of methods 1 and 2 for adjusting for inﬂation in studies relating to healthcare interventions in low- and middle-
income countries. In these hypothetical examples, the year of the costing is 2006 and the base year of the analysis is 2016. In the
example, US$ are being used, but the same approach would be applicable to international dollars.
Figure 2. Overview of the mixed method (method 3) for adjusting for inﬂation in studies relating to healthcare interventions in low- and
middle-income countries. In this hypothetical example, the year of the costing is 2006, the base year of the analysis is 2016, and 20% of
the resources used were “tradable.” In the example, US$ are being used, but the same approach would be applicable to international
dollars.
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Adjustment Method 2: Inﬂating the Local Currency Using
Local Inﬂation Rates and Then Exchanging to US$ or
International Dollars
Within this method, the costs are ﬁrst inﬂated using the local
currency’s inﬂation rates and are then converted to US$ or
international dollars using the exchange rate relating to the base
year of the analysis (Fig. 1B).
Nevertheless, in practice, many healthcare interventions use
imported commodities/goods, known as tradable resources
(such as laboratory equipment and many drugs; see Box 1).
A limitation of this method is that local inﬂation rates may not
accurately reﬂect changes in the prices of these tradable goods
that are often globally purchased and priced. When the inﬂation
rate for the local currency is higher than the US inﬂation rate, this
method can overestimate the adjusted cost related to these
tradable resources.
Kumaranayake6 recommended using this method unless the
healthcare intervention uses a relatively high proportion of
imported commodities (ie, tradable resources) or rapid inﬂation (eg,
rates .15-20%) has occurred, in which case it was recommended
that working in US$ (ie, method 1) would be more appropriate.
Adjustment Method 3: A Mixed Approach
For costing studies that have used the ingredients-based
approach (ie, microcosting),10 a more detailed estimate of
the inﬂated cost can be obtained. Within this method,
the costs of the healthcare intervention are stratiﬁed into
tradable and nontradable resources (Box 1). The costs of
Figure 3. Overview of the process of using data from other settings and adjusting for inﬂation.
Figure 4. Adjusting costs with local inﬂation rates that have already been reported in US$.
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the tradable resources are then converted into US$ or
international dollars using the exchange rate relating to the
time period the cost data were collected and then inﬂated
using US inﬂation rates (or when possible commodity-speciﬁc
price change rates) (Fig. 2). The costs of the nontradable
local resources are inﬂated using the local currency’s inﬂation
rates and then converted to US$ or international dollars
(Fig. 2).
A key advantage of this approach is that it is more accurate
than the other methods (Fig. 1). Nevertheless, it can be difﬁcult
to implement on previously published data as the results of
costing studies are not always reported in sufﬁcient detail. In
addition, in practice, it can be difﬁcult to separate resources in
this way. For example, many goods may only be partially
tradable because of trade barriers or a lack of transportation
infrastructure. Because of this, whether or not a resource is
tradable will depend on the speciﬁc study setting. A
practical method of separating resources in this way for studies
in low- and middle-income countries can be to treat the
resources that were imported as tradable and treat all other
resources as nontradable.
Recently, the Global Health Costing Consortium stated that this
is the preferred method within their reference case for estimating
the costs of global health services and interventions.18
A summary of the advantages and disadvantages of the different
output currencies and adjustment methods is presented in Table 1.
Ultimately, the difference in the adjusted costs from these
methods will depend on the speciﬁc country’s inﬂation and
exchange rates compared with the United States, and will
therefore vary for different countries. The differences can be very
signiﬁcant when the local inﬂation rates are higher than the US
inﬂation rates. The proportion of the total cost that is related to
tradable resources will also affect the difference between the
methods and inﬂuence which is most appropriate for a given study.
Using Data from Other Settings or Previous
Studies
These approaches for adjusting for inﬂation are also often
required when using cost data collected from a different study
setting or country. This is a very common necessity for studies
relating to settings with limited local cost data available. An
overview of this is presented in Figure 3.
The results of costing studies relating to low- and
middle-income countries are often expressed in US$ or
international dollars. When adjusting these previously published
costs for inﬂation using local inﬂation rates, that is, method 2
(Fig. 1B), it is vital that the costs are ﬁrst converted back to the
local currency using the exchange rate relating to the time period
the cost data were collected. The costs can then be inﬂated and
converted back to US$ or international dollars using the
exchange rate of the base year of the analysis (Fig. 4). This is
important because the exchange rates will change over time, and
not accounting for this could result in the costs being notably
overadjusted (Fig. 4).
Conclusions
Crucially, the most appropriate methodology for adjusting for
inﬂation will depend on the context of the study and the available
data.6,8 Generally, in studies related to healthcare interventions in
low- and middle-income countries, we would recommend using
method 3 when it is possible to stratify the resources into tradable
and nontradable. This should be possible during primary costing
studies but may not be when using previously published data
(such as analyses based on systematic literature reviews or cost
databases). In the cases when this is not possible, method 1 should
be used when there is high use of tradable resources and method
2 when there is high use of nontradable resources. The results
should be reported in US$ and/or international dollars, as well as
the local currency. As highlighted by Kumaranayake,6 what is most
important is that the methodology is transparently reported and
speciﬁed. Speciﬁcally, we recommend clear methodological
reporting and justiﬁcation regarding (1) the choice of the
measure of inﬂation, (2) the choice of the output currency, and
(3) the choice of the adjustment method, and, if applicable, (4) the
approach used for adjusting cost data from other settings.
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